Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio De Filippis

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Current Neuropharmacology|January 14, 2021
Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use DisorderGeorgios D Kotzalidis, Ginevra Lombardozzi, Marta Matrone, et al.
The Journal of Headache and Pain|April 1, 2006
Salivary cortisol, dehydroepiandrosterone-sulphate (DHEA-S) and testosterone in women with chronic migraineFrancesca Romana Patacchioli, Paola Monnazzi, Simona Simeoni, et al.
Frontiers in Psychiatry|November 29, 2018
Patterns of Management of Patients With Dual Disorder (Psychosis) in Italy: A Survey of Psychiatrists and Other Physicians Focusing on Clinical PracticeMassimo Clerici, Andrea de Bartolomeis, Sergio De Filippis, et al.
Neuroscience Letters|September 18, 2016
Cannabis use related to early psychotic onset: Role of premorbid functionMarianna Frascarelli, Adele Quartini, Lorenzo Tomassini, et al.
The Journal of Headache and Pain|October 28, 2008
Mental turmoil, suicide risk, illness perception, and temperament, and their impact on quality of life in chronic daily headacheSergio De Filippis, Denise Erbuto, Federica Gentili, et al.
Neuropsychiatric Disease and Treatment|June 29, 2018
Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of lifeIlaria Cuomo, Georgios D Kotzalidis, Simone de Persis, et al.
Neuropsychiatric Disease and Treatment|August 16, 2022
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice in Italy: Results from the RELIEVE StudySergio De Filippis, Anna Pugliese, Michael Cronquist Christensen, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|September 13, 2023
A comprehensive evaluation of adverse childhood experiences, social-emotional impairments, and neurodevelopmental disorders in cannabis-use disorder: Implications for clinical practiceGiada Trovini, Emanuela Amici, Piergiorgio Bauco, et al.
Frontiers in Psychiatry|April 19, 2021
Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic AntidepressantAlessandro E Vento, Simone de Persis, Sergio De Filippis, et al.
Frontiers in Psychiatry|December 19, 2023
Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational studyGinevra Lombardozzi, Giada Trovini, Emanuela Amici, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Current Neuropharmacology|January 14, 2021
Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use DisorderGeorgios D Kotzalidis, Ginevra Lombardozzi, Marta Matrone, et al.
The Journal of Headache and Pain|April 1, 2006
Salivary cortisol, dehydroepiandrosterone-sulphate (DHEA-S) and testosterone in women with chronic migraineFrancesca Romana Patacchioli, Paola Monnazzi, Simona Simeoni, et al.
Frontiers in Psychiatry|November 29, 2018
Patterns of Management of Patients With Dual Disorder (Psychosis) in Italy: A Survey of Psychiatrists and Other Physicians Focusing on Clinical PracticeMassimo Clerici, Andrea de Bartolomeis, Sergio De Filippis, et al.
Neuroscience Letters|September 18, 2016
Cannabis use related to early psychotic onset: Role of premorbid functionMarianna Frascarelli, Adele Quartini, Lorenzo Tomassini, et al.
The Journal of Headache and Pain|October 28, 2008
Mental turmoil, suicide risk, illness perception, and temperament, and their impact on quality of life in chronic daily headacheSergio De Filippis, Denise Erbuto, Federica Gentili, et al.
Neuropsychiatric Disease and Treatment|June 29, 2018
Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of lifeIlaria Cuomo, Georgios D Kotzalidis, Simone de Persis, et al.
Neuropsychiatric Disease and Treatment|August 16, 2022
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice in Italy: Results from the RELIEVE StudySergio De Filippis, Anna Pugliese, Michael Cronquist Christensen, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|September 13, 2023
A comprehensive evaluation of adverse childhood experiences, social-emotional impairments, and neurodevelopmental disorders in cannabis-use disorder: Implications for clinical practiceGiada Trovini, Emanuela Amici, Piergiorgio Bauco, et al.
Frontiers in Psychiatry|April 19, 2021
Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic AntidepressantAlessandro E Vento, Simone de Persis, Sergio De Filippis, et al.
Frontiers in Psychiatry|December 19, 2023
Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational studyGinevra Lombardozzi, Giada Trovini, Emanuela Amici, et al.
Pageof 7